Stock Why is Nvidia stock soaring before Q4 earnings? Here’s $65.9B reason by February 23, 2026 by February 23, 2026 Nvidia stock (NASDAQ: NVDA) ticked higher on Monday as Wall Street headed into the chipmaker’s Feb. 25 earnings report with… 0 FacebookTwitterPinterestEmail
Stock Why Tesla stock is down over 2% on Monday by February 23, 2026 by February 23, 2026 Tesla stock declined at the start of the new trading week, as investors assessed intensifying competition in autonomous driving and… 0 FacebookTwitterPinterestEmail
Stock We predicted Blue Owl stock price crash: what’s next? by February 23, 2026 by February 23, 2026 Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into… 0 FacebookTwitterPinterestEmail
Stock Merck creates separate oncology arm ahead of Keytruda patent loss by February 23, 2026 by February 23, 2026 Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen… 0 FacebookTwitterPinterestEmail
Stock Royal Bank of Canada stock double-tops ahead of Q1 earnings by February 23, 2026 by February 23, 2026 Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now… 0 FacebookTwitterPinterestEmail
Stock Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push by February 23, 2026 by February 23, 2026 Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box,… 0 FacebookTwitterPinterestEmail
Stock US stocks open flat after Trump raises global tariffs to 15% by February 23, 2026 by February 23, 2026 US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following… 0 FacebookTwitterPinterestEmail
Stock Almirall profit quadruples in 2025 as dermatology fuels growth push by February 23, 2026 by February 23, 2026 Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more… 0 FacebookTwitterPinterestEmail
Stock Citrini research: S&P 500 to drop 38% from 2026 highs by June 2028 by February 23, 2026 by February 23, 2026 In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of… 0 FacebookTwitterPinterestEmail
Stock Why is Arcellx stock up 80% today? Gilead’s $7.8B answer by February 23, 2026 by February 23, 2026 Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy… 0 FacebookTwitterPinterestEmail
